此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Ultrasound Guided Central Venous Vascular Access - Novel Needle Navigation Technology Compared With Conventional Method

2017年7月10日 更新者:Dr Mohd Shahnaz, MBBS, M Anes、University of Malaya

Ultrasound Guided Central Venous Vascular Access - Novel Needle Navigation Technology Compared With Conventional Method: A Prospective Randomized Study

Background: Central venous catheter (CVC) insertion is a very common procedure in the intensive care setting. A recent international guidelines advocated the use of ultrasound for routine internal jugular CVC insertion. The needle navigation technology is a new innovation, also known as guided positioning system (GPS) which allows clinician to visualize the needle position and trajectory in real time as it approaches the target. We hypothesised that the use of GPS would increase success rate and decrease performance time in vascular access procedures.

Objectives: To compare the success, efficacy and safety of the procedure using the ultrasound guidance (UG) with conventional versus GPS method.

Methods: This was a prospective randomized controlled study in a single centre - intensive care unit. 100 patients were randomized into two groups (50 each each). Subjects would receive CVC insertion via internal jugular vein using ultrasound guidance out of plane approach by conventional versus GPS method. Outcomes measured were the procedure efficacy, safety, level of operators' experience and their satisfaction.

研究概览

地位

完全的

条件

详细说明

Introduction Central venous catheter (CVC) insertion is a very common procedure in the intensive care setting. A recent international guideline advocates the use of ultrasound for routine internal jugular central venous catheter insertion1. The needle navigation technology is a new innovation, also known as guided positioning system (GPS) which allows clinician to visualize the needle position and trajectory in real time as it approaches the target. We hypothesised that the use of GPS would increase success rate and decrease performance time in vascular access procedures. The objectives of this study are to compare the success, efficacy and safety of central venous catheter insertion via internal jugular vein using the ultrasound guidance with conventional method versus needle navigation technology.

Methods:

This was a prospective randomized controlled study. It was conducted in a single centre - intensive care unit (ICU), University of Malaya Medical Centre, Kuala Lumpur, Malaysia from February 2016 to October 2016. The ethic committee approval was obtained from the Malaysian medical research and ethics committee, MREC at the www.nih.gov.my (NMRR-16-334-29476).

The inclusion criterion was patients in the ICU who required central venous vascular access. The exclusion criteria were refusal to participate in this study by patient or their legal representative and patient with known history of difficult central venous access at internal jugular vein (IJV). The procedure operators were doctors in anaesthesia residency program with various level of experiences classified into 3 groups: 1 to < 2 years, 2 to < 3years, 3 years and above. Simply speaking all the operators have had previous training in ultrasound guided vascular access procedure. This would ensure that patient's safety is not compromised.

Study would be proceeded after obtaining consent from patient or the next of kin. The emergency verbal consent would be taken if the next of kin was not immediately available with subsequent written consent to follow. The available operator would perform CVC insertion via IJV using ultrasound guidance out of plane approach either with conventional method or needle guidance technology.

Study Protocol:

After obtaining consent, a computer generated randomisation would be assigned to either using the conventional or GPS method. Identified operators using GPS method would receive a standard 5 minute briefing on the needle guidance technology and got to practice with the new technology using the vascular phantom (Blue Phantom Inc., Bothell, WA, USA). The operators were allowed to practice until they were ready to perform on real patient.

All procedure would be performed using the ultrasound machine, eZono 4000 with eZGuide (eZono, Jena, Germany) and linear array transducer L3-12NGS (3-12 MHz). This ultrasound machine2 has a built-in adaptive needle recognition software called eZGuide. The navigation technology of the ultrasound device is based on an electromagnetic field that communicates with a transducer and an electromagnetic sensor sheathed by a vascular access needle. Needle movements and related magnetic field variation allow navigation system to compute the locations of the transducer and needle in the three dimensional space. The ultrasound screen would display colour coded alignment of the needle and the position of the tip relative to the imaging plane (Figure 1). Superimposed on the image is the real-time electronic needle guidance system. The dashed line represents the predicted needle trajectory. The red box represents the depth that the needle will cross the plane of the ultrasound. The solid lines on either side of the dashed line represent the actual depth of the needle. The top left corner shows a diagram of the transducer-needle relation. This allowed the user to identify the correct needle trajectory, prior to puncturing the patient's skin and maintain the chosen route to the target anatomy. Operators assigned to use GPS method would have activated the eZGuide software while those performing conventionally would have the software technology turned off when using the ultrasound machine.

The procedure time was measured in seconds using a stopwatch. The performance time was defined as time measured from placing the needle on the skin to successful vessel puncture as indicated by blood withdrawn into the syringe.

研究类型

介入性

注册 (实际的)

100

阶段

  • 不适用

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Patients in the ICU who required central venous vascular access.

Exclusion Criteria:

  • Refusal to participate in this study by patient or their legal representative and patient with known history of difficult central venous access at internal jugular vein (IJV).

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
有源比较器:Conventional method
For the Conventional method of ultrasound guided central venous catheter insertion,we use the ultrasound machine, eZono 4000 and linear array transducer L3-12NGS (3-12 MHz)
实验性的:GPS method
For the GPS method, we use the ultrasound machine, eZono 4000 with built-in adaptive needle recognition software called eZGuide (eZono, Jena, Germany) and linear array transducer L3-12NGS (3-12 MHz).

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
The procedure efficacy justified by successful cannulation.
大体时间:0-120 seconds
The procedure efficacy justified by successful cannulation based on the performance time and number of attempts,
0-120 seconds

次要结果测量

结果测量
措施说明
大体时间
Safety of procedure and complications.
大体时间:During and within 24 hours after procedure.
The safety of the procedure by identifying any potential complications occur, i.e. secondary tissue injury, hematoma, bleeding, pneumothorax, haemothorax or arterial puncture.
During and within 24 hours after procedure.
Operators' satisfaction.
大体时间:within 1 week
Level of operators' satisfaction.
within 1 week

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:MOHD SHAHNAZ HASAN, MBBS、University of Malaya

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2016年2月1日

初级完成 (实际的)

2016年10月1日

研究完成 (实际的)

2016年10月31日

研究注册日期

首次提交

2017年7月4日

首先提交符合 QC 标准的

2017年7月10日

首次发布 (实际的)

2017年7月11日

研究记录更新

最后更新发布 (实际的)

2017年7月11日

上次提交的符合 QC 标准的更新

2017年7月10日

最后验证

2017年7月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • NMRR-16-334-29476

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

Conventional method的临床试验

订阅